Business Context and Reporting Period
This Form 8-K was filed by Pono Capital Two, Inc., a special purpose acquisition company, with an earliest reported event date of May 3, 2023. The filing relates to the proposed business combination with SBC Medical Group Holdings Inc. and the extension of Pono’s deadline to complete a business combination.
Material Transaction and Key Terms
- Pono’s stockholders were scheduled to vote on May 5, 2023 on an amendment extending the business-combination deadline from May 9, 2023 to February 9, 2024.
- On May 3, 2023, Pono entered into non-redemption agreements with unaffiliated holders of an aggregate 773,682 Class A common shares.
- Those holders agreed not to redeem their shares in connection with the extension proposal.
- Upon completion of Pono’s initial business combination, sponsor Mehana Capital, LLC agreed to transfer Company common shares to the participating stockholders.
- Pono may enter into additional non-redemption agreements. No additional funds will be deposited into the trust account.
Financial Metrics and Liquidity
The filing does not provide current-period or prior-period revenue, profit, cash flow, margins, debt, liquidity balances, trust-account balance, redemption price, or other operating financial metrics. It states that the redemption price would equal the applicable per-share amount held in the trust account, including certain interest, divided by the number of outstanding public shares.
Guidance, Outlook, Risks, and Unusual Items
- Completion of the proposed business combination is not assured and remains subject to stockholder approval and other closing conditions.
- Identified risks include excessive redemptions, failure to satisfy Nasdaq listing standards, termination of the merger agreement, legal proceedings, disruption to SBC’s business, the need for additional capital, and uncertainty regarding SBC’s future financial performance and market opportunities.
- The extension amendment and non-redemption agreements are unusual transaction-related items; the filing does not quantify the number of shares the sponsor may transfer or the resulting dilution.
- Forward-looking statements are subject to substantial risks and uncertainties, and the filing disclaims any obligation to update them except as required by law.
Investor Verification Priorities
- Verify the outcome of the May 5, 2023 stockholder vote and whether the deadline was extended to February 9, 2024.
- Confirm the final number of shares subject to non-redemption agreements and any additional agreements entered into.
- Review the trust-account balance, actual redemption price, total redemptions, and remaining public shares.
- Review the definitive proxy statement and merger documents for closing conditions, dilution, sponsor share transfers, and transaction valuation.
- Assess whether the proposed business combination was completed and whether SBC or Pono required additional financing.